Drug Trial Radar · NCT02285088
A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
Last checked: Nov 20, 2026Latest source record: Feb 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
133
Actual
Start
Dec 2014
Primary completion
Mar 2017
Study completion May 2017
Sponsor
- Lead sponsor
- Global Blood TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 6, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of GBT440 compared with placebo in healthy subjects and subjects with sickle cell disease (SCD).
Conditions
- Healthy Subjects
- Sickle Cell Disease
Interventions
GBT440Drug
GBT440 will be administered as oral capsules
PlaceboDrug
Matching placebo will be administered as oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety, as assessed by frequency and severity of adverse events (AEs), and changes in vital signs, 12-lead electrocardiograms (ECGs), and laboratory assessments as compared to baselineTime frame: 30 - 118 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Guy's Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.